BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 14524284)

  • 21. Leptin-mediated cytokine release and migration of eosinophils: implications for immunopathophysiology of allergic inflammation.
    Wong CK; Cheung PF; Lam CW
    Eur J Immunol; 2007 Aug; 37(8):2337-48. PubMed ID: 17634954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T-helper 2 cytokines attenuate senescent eosinophil activation by the CXCR4 ligand stromal-derived factor-1alpha (CXCL12).
    Dulkys Y; Buschermöhle T; Escher SE; Kapp A; Elsner J
    Clin Exp Allergy; 2004 Oct; 34(10):1610-20. PubMed ID: 15479278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-allergic therapies: effects on eosinophil progenitors.
    Baatjes AJ; Sehmi R; Saito H; Cyr MM; Dorman SC; Inman MD; O'Byrne PM; Denburg JA
    Pharmacol Ther; 2002 Jul; 95(1):63-72. PubMed ID: 12163128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allergic diseases.
    Donohoe MR
    Lippincotts Prim Care Pract; 1997; 1(2):117-28. PubMed ID: 9166620
    [No Abstract]   [Full Text] [Related]  

  • 25. EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders.
    Boyman O; Kaegi C; Akdis M; Bavbek S; Bossios A; Chatzipetrou A; Eiwegger T; Firinu D; Harr T; Knol E; Matucci A; Palomares O; Schmidt-Weber C; Simon HU; Steiner UC; Vultaggio A; Akdis CA; Spertini F
    Allergy; 2015 Jul; 70(7):727-54. PubMed ID: 25819018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging drugs for ocular allergy.
    Leonardi A
    Expert Opin Emerg Drugs; 2005 Aug; 10(3):505-20. PubMed ID: 16083326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytokine and anti-cytokine therapy for the treatment of asthma and allergic disease.
    Holgate ST
    Cytokine; 2004 Nov 21-Dec 7; 28(4-5):152-7. PubMed ID: 15588688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-IgE antibodies for the treatment of IgE-mediated allergic diseases.
    Chang TW; Wu PC; Hsu CL; Hung AF
    Adv Immunol; 2007; 93():63-119. PubMed ID: 17383539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiallergic effects of Vitis amurensis on mast cell-mediated allergy model.
    Kim SH; Kwon TK; Shin TY
    Exp Biol Med (Maywood); 2008 Feb; 233(2):192-9. PubMed ID: 18222974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological modulation of Th17.
    De Sanctis JB; Garmendia JV; Moreno D; Larocca N; Mijares M; Di Giulio C; Salazar-Bookaman M; Wojewodka G; Radzioch D
    Recent Pat Inflamm Allergy Drug Discov; 2009 Jun; 3(2):149-56. PubMed ID: 19519592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Eosinophil in allergic and non-allergic inflammation].
    Czarnobilska E; Obtułowicz K
    Przegl Lek; 2005; 62(12):1484-7. PubMed ID: 16786779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current prospective of anti-IL-4, -IL-9, and -IL-13 therapies in allergic disease.
    Steinke JW
    Recent Pat Inflamm Allergy Drug Discov; 2010 Nov; 4(3):222-30. PubMed ID: 20807191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drugs for allergic disorders.
    Treat Guidel Med Lett; 2010 Feb; 8(90):9-18; quiz 2 p following 18. PubMed ID: 20094023
    [No Abstract]   [Full Text] [Related]  

  • 34. [Therapeutic possibilities and clinical effects of IgE level modulation in allergic diseases].
    Bobrowska M; Stelmach I
    Pneumonol Alergol Pol; 2004; 72(1-2):70-4. PubMed ID: 15757296
    [No Abstract]   [Full Text] [Related]  

  • 35. Customized antigens for desensitizing allergic patients.
    Ferreira F; Wallner M; Thalhamer J
    Adv Immunol; 2004; 84():79-129. PubMed ID: 15246251
    [No Abstract]   [Full Text] [Related]  

  • 36. Emedastine difumarate: a review of its potential ameliorating effect for tissue remodeling in allergic diseases.
    Murota H; Katayama I
    Expert Opin Pharmacother; 2009 Aug; 10(11):1859-67. PubMed ID: 19558341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel approaches to the inhibition of mast cells in allergic disease.
    Bradding P
    Clin Exp Allergy; 2008 May; 38(5):704-8. PubMed ID: 18325033
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunotherapy in allergies: an update.
    Calamita Z; Potthast SB
    Inflamm Allergy Drug Targets; 2013 Feb; 12(1):12-8. PubMed ID: 22924457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New directions in therapy for ocular allergy.
    el-Defrawy S; Jackson WB
    Int Ophthalmol Clin; 1996; 36(2):25-44. PubMed ID: 8950631
    [No Abstract]   [Full Text] [Related]  

  • 40. Molecular therapy versus standard treatment in allergy (Review).
    Grzela K; Lazarczyk M; Dziunycz P; Milewski L; Niderla J; Grzela T
    Int J Mol Med; 2004 Jul; 14(1):3-22. PubMed ID: 15202012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.